Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Wright Reports
$75.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Symmetry Medical Inc Reaffirms FY 2013 Guidance


Thursday, 2 May 2013 07:01am EDT 

Symmetry Medical Inc announced that for fiscal 2013, it expects revenue to be in the range of $420-$440 million. The Company expects fiscal 2013 GAAP earnings per diluted share to be in the range of $0.35-$0.47 and as adjusted earnings per diluted share (EPS) to be in the range of $0.64-$0.76. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $434 million and EPS of $0.71 for fiscal 2013.